Skip to content

Use Cases.


Created VR safety training for 4,000 US government warehouse personnel that reduced days away due to injury by 72-percent over a 3 year period of time.

*Results documented in University of Washington third party double blind study.


Teaming up with a global contractor, LightValve created cybersafe training that helped a large federal agency reduce phishing successes by 99.5% and slash 5.5 man-years from its old learning programs. The agency later received 1st Place in the NIST FISSEA annual contest for best Federal Information Security Program.


LightValve helped a Silicon Valley accounting firm’s staff build customer engagement skills with a custom blended learning program. Employees were so satisfied with the results that the firm’s Glassdoor Best Places to Work ranking soared 47 percentage points in one year, and employees ranked their leader the Glassdoor Best CEO.

*Protiviti, a division of Robert Half International, Glassdoor Best Places to Work ranking, and senior manager named Best CEO by Glassdoor.


LightValve had a multi-year relationship to develop and produce product, sales and technical information for a Japan-based auto manufacturer. The OEM experienced a double-digit improvement in sales, permanently displaced one competitor as the #2 best-selling brand, and earned a multi-year ranking as the Best Certified Used Cars program in the US.

*J.D. Power and Associates Customer Satisfaction Index. IntelliChoice Best Certified Used Car Program.


LightValve developed safety training that helped reduce yearly medical costs by $3,022 per worker each year at an injury-plagued aerospace manufacturing plant, with a dramatic drop in annual premiums.

A third-party double-blind study of 1,000 repair plant workers, Corpus Christi, TX


LightValve developed a medical video game that was the first-ever to use a third person shooter format allowing cancer patients blast their own cancer cells. A clinical study of hundreds of participants, peer-reviewed in PEDIATRICS journal, demonstrated significant increases in chemo adherence.